Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02739893 · ClinicalTrials.gov registry record · NA
Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy
A NA study of Colonoscopy, Colorectal, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT02739893: Completed NA study of Colonoscopy, Colorectal, sponsored by University of Alabama at Birmingham.
NCT02739893 is a NA study of Colonoscopy, Colorectal that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02739893, a NA study of Colonoscopy, Colorectal, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to see if use of ScopeGuide, as compared to the traditional colonoscope, improves successful completion of colonoscopy procedures as evaluated by ease of completion, time to completion, and reduction in the number of mechanical loops and external maneuvers required to advance the scope. Other outcome measures include looking at the amount of sedation required (independent of weight) and polyp rate detection.
Primary Outcome
time in minutes to reach cecum destination in each arm
Conditions Studied
Interventions
- PROCEDURE Scope Guide Assist
- PROCEDURE Standard procedure for colonoscopy
Study Locations (1)
Alabama
- University of Alabama - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-02-07 |
| Phase | NA |
What the finished NCT02739893 record still lists
NCT02739893 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Colonoscopy, Colorectal appearing as the primary indexed condition, and to 2 interventions - of which Scope Guide Assist is the first listed.
NCT02739893 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02739893 about?
NCT02739893 is a clinical study titled "Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy". The aim of this study is to see if use of ScopeGuide, as compared to the traditional colonoscope, improves successful completion of colonoscopy procedures as evaluated by ease of completion, time to completion, and reduction in the number of mechanical loops and external maneuvers required to advanc...
What is the current status of trial NCT02739893?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-01. Estimated completion is 2019-02-07.
What conditions does trial NCT02739893 study?
This clinical trial studies the following conditions: Colonoscopy, Colorectal.
What interventions are being tested in trial NCT02739893?
The interventions under investigation include: Scope Guide Assist (PROCEDURE), Standard procedure for colonoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02739893?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02739893 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02739893's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia